Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Boehringer Ingelheim
Covington
Medtronic
AstraZeneca

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,673,919

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,673,919
Title:Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
Abstract: This invention concerns N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N\'-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
Inventor(s): Vernier; Jean-Michel (San Diego, CA), Kim; Hong Woo (San Diego, CA), Hitchcock; Marion (Berlin, DE), Yan; Shunqi (Irvine, CA)
Assignee: Ardea Biosciences, Inc. (San Diego, CA)
Application Number:13/259,239
Patent Claims:see list of patent claims

Details for Patent 8,673,919

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Ardea Biosciences, Inc. (San Diego, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Boehringer Ingelheim
Julphar
Accenture
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.